Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by the Thyssen Group in 1990
|
| gptkbp:ceo |
Dr. Klaus W. H. Wiegand
|
| gptkbp:dissolved |
Not dissolved
|
| gptkbp:employees |
around 1,500
|
| gptkbp:established |
1865
|
| gptkbp:founded |
1865
|
| gptkbp:founder |
gptkb:Alfred_Nobel
|
| gptkbp:headquarters |
gptkb:Troisdorf,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dynamit Nobel Gmb H
|
| gptkbp:industry |
explosives
|
| gptkbp:key_people |
Dr. Klaus W. H. Wiegand
|
| gptkbp:location |
gptkb:government_agency
|
| gptkbp:net_worth |
€50 million (approx.)
|
| gptkbp:parent_company |
gptkb:Dynamit_Nobel_AG
|
| gptkbp:products |
explosives
specialty chemicals ammonium nitrate blasting agents detonators propellants |
| gptkbp:region |
Worldwide
|
| gptkbp:revenue |
€500 million (approx.)
|
| gptkbp:subsidiary |
Dynamit Nobel Defence Gmb H
Dynamit Nobel Medical Gmb H |
| gptkbp:type |
private limited company
|
| gptkbp:website |
www.dynamitnobel.com
|
| gptkbp:bfsParent |
gptkb:Dynamit_Nobel
|
| gptkbp:bfsLayer |
4
|